Temporal analysis of hepatitis C virus cell entry with occludin directed blocking antibodies. - Test2 - elhamkhani - TriplyDB

Temporal analysis of hepatitis C virus cell entry with occludin directed blocking antibodies.

Temporal analysis of hepatitis C virus cell entry with occludin directed blocking antibodies.

http://www.wikidata.org/entity/Q34649662

about

Hepatitis C virus relies on lipoproteins for its life cycle Host-Targeting Agents to Prevent and Cure Hepatitis C Virus Infection Genetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine Design Rescue of the 1947 Zika Virus Prototype Strain with a Cytomegalovirus Promoter-Driven cDNA Clone The impact of hepatitis C virus entry on viral tropism HepG2 cells mount an effective antiviral interferon-lambda based innate immune response to hepatitis C virus infection.A Novel Human Radixin Peptide Inhibits Hepatitis C Virus Infection at the Level of Cell Entry.The Humoral Immune Response to HCV: Understanding is Key to Vaccine Development.Hepatitis C virus genetics affects miR-122 requirements and response to miR-122 inhibitors.Hepatitis C virus life cycle and lipid metabolism New Methods in Tissue Engineering: Improved Models for Viral Infection Claudin-6 and Occludin Natural Variants Found in a Patient Highly Exposed but Not Infected with Hepatitis C Virus (HCV) Do Not Confer HCV Resistance In Vitro.Lipoprotein Receptors Redundantly Participate in Entry of Hepatitis C Virus.Selection of a hepatitis C virus with altered entry factor requirements reveals a genetic interaction between the E1 glycoprotein and claudins Club cells surviving influenza A virus infection induce temporary nonspecific antiviral immunity.5-HT2 receptors facilitate JC polyomavirus entry.The ins and outs of hepatitis C virus entry and assembly.TIM-1 Promotes Hepatitis C Virus Cell Attachment and Infection.CD81 and hepatitis C virus (HCV) infection.Attachment and Postattachment Receptors Important for Hepatitis C Virus Infection and Cell-to-Cell Transmission.Incorporation of primary patient-derived glycoproteins into authentic infectious hepatitis C virus particles.Activated macrophages promote hepatitis C virus entry in a tumor necrosis factor-dependent manner.A small-molecule inhibitor of hepatitis C virus infectivity.Viral Determinants of miR-122-Independent Hepatitis C Virus Replication.Ectopic delivery of miR-200c diminishes hepatitis C virus infectivity through transcriptional and translational repression of Occludin.TNF superfamily members promote hepatitis C virus entry via an NF-κB and myosin light chain kinase dependent pathway.The Serum Very-Low-Density Lipoprotein Serves as a Restriction Factor against Hepatitis C Virus Infection.Critical interaction between E1 and E2 glycoproteins determines binding and fusion properties of hepatitis C virus during cell entry.The ancient claudin Dni2 facilitates yeast cell fusion by compartmentalizing Dni1 into a membrane subdomain.Monoclonal antibodies against occludin completely prevented hepatitis C virus infection in a mouse model.CD81 Receptor Regions outside the Large Extracellular Loop Determine Hepatitis C Virus Entry into Hepatoma Cells.HCV envelope glycoproteins in evirion assembly and entry Current and future targets of antiviral therapy in the hepatitis C virus life cycle HCV Receptors and Virus Entry

P2860

Q26766119-00525556-432B-4450-9B84-42093686511A Q26779128-EF1ECF96-1943-4285-BD70-41AD53D8EA77 Q26801759-453E309E-43EE-48A8-AE00-CC552B59E59A Q27468652-D3F135A2-A68C-444A-B393-7887380D602D Q27693297-00EA47D4-A174-42D5-9842-4622069E671C Q34250323-C83FA458-2327-48F2-AED4-F20A9AE71360 Q34441502-4CB2080A-EE7D-473C-8E85-36AF4019FB1C Q34481429-572E0691-4234-42D9-86BC-9FEA58522C08 Q34539024-79EBCB63-EE87-4E73-A3DF-71198B39300C Q34792436-0E6FCA01-57C5-462F-AEA3-DDC1492DD627 Q35431256-32023B2E-5B8D-4041-B399-2AB4C21F7B0E Q35839680-76F29940-1C2E-4876-811F-C45D93793A81 Q36010861-1EA04272-43CA-46B0-AC9E-DB9EC0A2D936 Q36105419-01D0F63F-48F5-463A-86E7-2230DF0A7B6F Q36802513-50A3F126-3C95-4DB5-BBFA-1B638DC11E71 Q37336799-11EC50FC-5464-442B-8AED-ECC10B32A28A Q37498626-FC2B76DC-B1A7-46FF-AF0F-5B3DA7042A52 Q37560808-F357D181-99FF-4C29-A94F-F0E5FD2CF8B8 Q37611819-D5BC4CB1-D36F-4CDB-AD1D-98DD8EBB916C Q38707908-1BFDE124-ACE1-4F6C-A6A4-EAAB6CF92125 Q39000841-602061FE-9084-4617-815C-EB44B5A5335E Q39060138-CFC4ADE0-564A-4C5E-863F-5978C69A41AB Q39069509-73843B57-908F-40DA-B960-B41B835B098D Q39682302-14C55A32-ADEC-4D6E-B124-117506E190DF Q40148655-2A1B2D37-DE10-45F8-AB1B-91F76ACF51E5 Q40407185-128DC324-771F-4A2F-B72E-79EFC1D55197 Q41295530-B27C0317-72AB-43A9-9F2F-9D3305D1D488 Q42269411-DED98119-787F-436E-B13C-3F5AC6B1B0AB Q47183822-41C278DE-F248-4E6B-9218-208EA58D1929 Q50043321-45D72846-23CD-4AE9-918D-8069AB7BF1E1 Q54231580-E85189ED-C38C-4353-BC6C-747654A98C71 Q56910948-491107ED-4190-4379-9991-28551D8EE593 Q57071775-6C7BA17D-70A1-456C-A6B6-9763E7A62FB0 Q57564402-CBB3CCC2-3078-4F87-89E7-E461CC7A22FD

P2860

Temporal analysis of hepatitis C virus cell entry with occludin directed blocking antibodies.

http://www.wikidata.org/entity/Q34649662

description

2013 nî lūn-bûn

@nan

2013 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի մարտին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Temporal analysis of hepatitis ...... directed blocking antibodies.

@ast

Temporal analysis of hepatitis ...... directed blocking antibodies.

@en

Temporal analysis of hepatitis ...... directed blocking antibodies.

@nl

type

label

Temporal analysis of hepatitis ...... directed blocking antibodies.

@ast

Temporal analysis of hepatitis ...... directed blocking antibodies.

@en

Temporal analysis of hepatitis ...... directed blocking antibodies.

@nl

prefLabel

Temporal analysis of hepatitis ...... directed blocking antibodies.

@ast

Temporal analysis of hepatitis ...... directed blocking antibodies.

@en

Temporal analysis of hepatitis ...... directed blocking antibodies.

@nl

P1433

Q34649662-EDFFF188-D2ED-493D-879C-458A4606FF09

P1476

Q34649662-736C1F82-9AD9-486F-AE05-27A830537624

P2093

Q34649662-047AA054-A6E9-4FB2-A038-70A5FCF0C7CC

Q34649662-049F5B03-BEA7-485A-B744-4505840982C7

Q34649662-0BE74282-B120-4643-A5A3-258A56EB9B7F

Q34649662-44EE82B8-2714-480A-9A42-CECDFE78FD2D

Q34649662-5AA41301-3F46-407C-827A-C99F1F83CEB6

Q34649662-7C3FB04C-E95C-4C72-B1D4-F5D5A51A6B16

Q34649662-BD1C82A8-C14D-4470-B19C-A7BC5D7CDE6A

P2860

Q34649662-0166A82B-2059-4E9E-8AC1-524386019AE7

Q34649662-05C49EB9-785C-4385-9A34-7E0470F2E23A

Q34649662-0607B7B1-E388-46D9-AED6-1FEB2B188937

Q34649662-06BB2F84-BE2E-431C-AE70-4513D106246E

Q34649662-0ED9A52E-4BA2-4672-A713-98309236DEF2

Q34649662-1F171ED0-441F-4430-AA21-AA4CEFC1BBED

Q34649662-27CC9AE6-7761-4978-874E-3C3A1903D0B4

Q34649662-2AC1AD8E-8AF1-4702-9686-FC2E871C4486

Q34649662-30ADF740-6B3F-4056-A389-EBCBC1E1F9EC

Q34649662-31A3D3D2-0DCC-4389-ABB8-1C6B5B4A019D

P304

Q34649662-11C6BE38-072B-4047-9D52-1BA44D51C15E

P31

Q34649662-122B6179-B573-4D3A-9095-B2A9DB7D4A50

P356

Q34649662-97E208A9-86B8-40E0-8A58-00132C7AE132

P433

Q34649662-58A47214-CAEA-4FE6-957C-864689BDD5EF

P478

Q34649662-9BB38258-C12C-49CB-8A57-7555883B6398

P50

Q34649662-7AD805F2-64F0-483E-9601-64FDF2709FD4

P577

Q34649662-A02AE03E-26CE-4D79-A2C6-707617389CAD

P5875

Q34649662-F33221EB-A407-4BD7-8D23-8467A7941DBE

P698

Q34649662-97FE4F0E-B4CA-4BE9-AC1F-A58B0A4894E7

P921

Q34649662-542F8C8A-C8B3-4E6E-9FD7-601E5C090DA9

P932

Q34649662-0817DBA3-DC9B-4E7B-8E51-B6554B307234

P356

JOURNAL.PPAT.1003244

P1433

P1476

Temporal analysis of hepatitis ...... directed blocking antibodies.

@en

P2093

Ana Parra Martín

http://www.w3.org/2001/XMLSchema#string

Benjamin Israelow

http://www.w3.org/2001/XMLSchema#string

Chati Zony

http://www.w3.org/2001/XMLSchema#string

Christopher M Narbus

http://www.w3.org/2001/XMLSchema#string

Maria L Michta

http://www.w3.org/2001/XMLSchema#string

Marion Sourisseau

http://www.w3.org/2001/XMLSchema#string

Sharon E Hopcraft

http://www.w3.org/2001/XMLSchema#string

P2860

Binding of hepatitis C virus to CD81

The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus.

Evidence for a functional RNA element in the hepatitis C virus core gene

Robust hepatitis C virus infection in vitro.

Time- and Temperature-Dependent Activation of Hepatitis C Virus for Low-pH-Triggered Entry

Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras

Different Domains of CD81 Mediate Distinct Stages of Hepatitis C Virus Pseudoparticle Entry

Characterization of the Early Steps of Hepatitis C Virus Infection by Using Luciferase Reporter Viruses

Hepatitis C Virus Entry Depends on Clathrin-Mediated Endocytosis

Hepatitis C Virus Entry Requires a Critical Postinternalization Step and Delivery to Early Endosomes via Clathrin-Coated Vesicles

P304

e1003244

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PPAT.1003244

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Matthew J. Evans

P577

2013-03-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236106123

http://www.w3.org/2001/XMLSchema#string

P698

23555257

http://www.w3.org/2001/XMLSchema#string

P921

P932

3605286

http://www.w3.org/2001/XMLSchema#string